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 Conclusions: The QVH tool provided a method to assess how well the 
prescription dose to target volumes was met in the treatment plans of 
this study. The tool could be used to identify a single suboptimal plan 
and to compare groups of plans which cannot be distinguished by 
means of the one-dimensional QF value. The QVH tool could, for 
example, be used in the quality assurance of a multi-centre trial, and 
for visualizing the learning curve of multiple dose level treatment 
planning in routine clinical practice. It could provide a valuable 
contribution to level 3 reporting of ICRU report 83. 
1 Duprez et al. IJROBP 2011 
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Purpose/Objective: Recently, a Cyberknife (CK) with an MLC became 
available. A key CK feature is easy delivery of non-coplanar (n-CP) 
beams. Objective evidence for added value of such beams is mostly 
lacking, partly because a common TPS for both systems did not exist 
until recently. Moreover, commercial TPS require trial-and-error 
tweaking of plan parameters for individual patients, making the 
outcome of planning highly user-dependent. With the recent MLC 
introduction, our in-house algorithm for multi-criterial plan 
optimization, iCycle, can now also optimize IMRT for CK. With iCycle, 
plan generation is fully automatic (no per patient tweaking), allowing 
objective comparison of treatment strategies in a single TPS. In this 
study we used iCycle to compare n-CP CK and CP linac approaches for 
prostate cancer. 
Materials and Methods: For 10 patients, iCycle was used to 
automatically generate plans with optimized profiles and beam angles 
for the CK and a conventional linac, emulating HDR brachytherapy 
dosimetry. For the linac, the beam search space contained 72 
coplanar orientations (separation 5°). For both systems, Pareto 
optimal IMRT plans were automatically generated, containing 1-30 
optimized beam directions (60 plans per patient), delivering 4 
fractions of 9.5Gy. Low rectum dose was the highest priority OAR 
objective for generating optimal plans within hard constraints, 
following achievement of a PTV V95 of ±99%.Other OARs considered 
were urethra, bladder, penis, scrotum, and femoral heads. 
Results: Both for the CK and the linac, PTV V95 was >99%. For both 
systems, plan quality did heavily depend on the number of beams 
included in the plan. For CK, rectum Dmean, V40Gy, V60Gy, and D1cc in 25 
beam plans were on average 50%, 67%, 71% and 15% lower than in 11 
beam plans, for equal PTV coverage. For 25 beam plans, differences 
between CK and linac in PTV- and peripheral zone Dmean and D98% were 
on average smaller than 0.3% (p>0.05), while the CK plans had 
18.5±8.0%, 23.2±14.1%, 21.4±20.8%, and 3.0±3.8% lower rectum Dmean, 
V40Gy, V60Gy, and D1cc, respectively (p=0.002; for all 10 patients, all 4 
rectum parameters were lowest for CK). There were no differences in 
urethra Dmean and D2% and in bladder Dmean. Bladder D2% was 2.5% lower 
for CK (p=0.002). For the femoral heads, Dmean and D2% were 20% and 
10% lower in CK plans (p=0.002). In all plans, penis/scrotum Dmean and 
D2% were lower than 2Gy and 4Gy, respectively, as imposed by hard 
constraints. Delivery time of 25 beam CK plans was 18.1±0.5 min, 
including imaging and correction for each beam.  
Conclusions: Non-coplanar hypo-fractionated treatment of prostate 
cancer with a Cyberknife did strongly reduce rectum dose compared 
to coplanar linac plans. For both systems, 25 beam plans greatly 
improved rectum dose compared to 11 beam plans. Due to the MLC, 
25 beam CK non-coplanar plans could be delivered in only 18 minutes, 
including image-guided beam-tumour alignment before delivery of 
each beam. 
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Purpose/Objective: The PARSPORT trial (CRUK/03/005) demonstrated 
that parotid-sparing intensity-modulated radiotherapy (IMRT) achieved 
a significant reduction in severe xerostomia compared with 
conventional radiotherapy in patients being treated for squamous cell 
carcinoma of the head and neck. An unexpected result of the trial was 
a significantly higher incidence of acute fatigue in patients 
randomised to receive IMRT. Analysis of trial data has shown that this 
correlates with increased radiation doses to central nervous system 
(CNS) structures. Based on this analysis potentially valuable dose-
volume constraints were implemented as inverse treatment planning 
objectives to explore the ability to reduce the dose to CNS structures 
without compromising the dose distributions to the tumour and 
normal tissues. 
Materials and Methods: A retrospective planning study was performed 
for 9 local patients – 3 each with tumours of the hypopharynx, 
oropharynx and nasopharynx. Relevant additional CNS structures were 
delineated by an experienced radiation oncologist. A 7-field inverse 
planned IMRT technique was used to produce clinically acceptable 
plans. Maximum dose-volume objectives were then introduced for the 
brainstem and cerebellum, the plans re-optimised and the level of 
cerebellum and brainstem dose-sparing assessed. The effect of the 
primary disease site on the ability to meet the constraints was 
investigated. 3D dose analysis was performed to assess the differences 
in the dose-distributions in other regions upon introduction of the 
constraints. 
Results: Introducing the additional CNS constraints into the treatment 
plan optimisation allowed significant dose-sparing to the cerebellum 
and brainstem to be achieved without compromising clinical plan 
assessment measures. Figure 1 shows the percentage improvement in 
the dose-volume statistics of interest when the CNS objectives were 
introduced. 
 
 
Figure 1: Percentage improvement in dose-volume statistics for the 
CNS structures upon introducing the CNS objectives. The white values 
indicate where the proposed constraints were achieved. For Hyp – 2 
the CNS constraints were already achieved prior to introducing the 
additional objectives into the plan optimisation. Many, but not all, of 
the CNS constraints could be achieved for most patients. Fewer 
constraints could be achieved for nasopharyngeal primaries compared 
with oropharyngeal and hypopharyngeal cancers. 3D dose analysis 
indicated that the dose reduction to the CNS structures resulted in 
consistent patterns of increased doses to uncontoured regions in the 
neck. 
Conclusions: It has been demonstrated that it is feasible to 
implement constraints to reduce the dose-distribution to the 
brainstem and cerebellum without compromising tumour coverage or 
sparing of organs at risk. However, the increased doses delivered to 
the neck should be carefully considered when assessing the dose-
distributions of plans produced using this technique. 
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Purpose/Objective: SBRT aims to deliver high doses in few fractions, 
thus requiring high confidence in accuracy of the treatment planning 
and delivery process. Being one source of uncertainty, respiratory 
motion is usually accounted for by 4DCT imaging and deriving the 
internal target volume (ITV) as basis of the PTV definition. In doing so, 
variations of breathing patterns and motion-related underestimation 
of normal tissue dose are not considered. In this study, dose 
accumulation methods are proposed, incorporated into DVH 
computation, and applied for DVH analyses for SBRT plans of liver and 
lung lesions. 
Materials and Methods: The study is based on liver and lung SBRT 
plans of 6 patients [5 fractions; 56 Gy to ITV; ITV derived from 10-
phase 4DCT; PTV = ITV + 4 mm margin; dose delivery by Varian VMAT]. 
Two approaches are followed for the analysis of respiratory motion 
effects. First, the planning CT (average CT of the 4DCT) and the 
breathing phases of the 4DCT are non-linearly registered. The 
resulting vector fields are applied for deforming the planned dose 
distribution; the altered doses are accumulated and the resulting 
DVHs evaluated (DVHacc). For the second approach, breath curves 
measured during 4DCT data acquisition (Siemens Somatom with Anzai 
belt) are analyzed wrt. patient-specific variations in breath 
amplitude. A regression is performed between the registration vector 
fields and the corresponding values from the breath curve. The linear 
model is then used to scale the original vector fields acc. to the 
breath curve analysis results, and the scaled fields are applied for 
dose accumulation and DVH analysis (DVHscaled). DVHacc and DVHscaled 
analysis results are compared to corresponding values for the 
originally planned dose distribution and DVHs (DVHorig). 
Results: The breath curves mainly reflect regular breathing patterns. 
The DVH analyses primarily illustrate motion-related dose blurring 
effects: maximum GTV point doses seen in DVHorig are smoothed out in 
DVHacc and DVHscaled. As expected, the minimum GTV point dose also 
decrease when analyzing DVHscaled (up to >4 Gy compared to DVHorig). 
However, minimum GTV point doses are not observed to fall below 
the prescribed dose in either DVHacc or especially DVHscaled. Further, 
DVH-related measures for normal tissue exposure are only marginally 
affected. For example, V20Gy (lungs) and V30Gy (liver) of DVHorig, 
DVHacc,and DVHscaled correspond within 1-2 volume percentage for all 
plans. 
Conclusions: Accounting for respiratory motion during SBRT treatment 
planning offers higher confidence in the accuracy of especially the 
treatment planning process, but still remains challenging. For the 
present patients and the proposed dose accumulation methods, 
motion-related changes of DVH measures were clinically acceptable. 
However, additional uncertainties like interplay effects (due to the 
IMRT character of VMAT) still need to be considered.  
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Purpose/Objective: The 2D-bMLC concept aims to provide quick 
aperture modulation. We therefore developed a treatment planning 
system (TPS) for ultra-fast rotational IMRT with the 2D-bMLC. For 
dosimetric evaluation patient plans with delivery times of 20-60s per 
fraction were optimized and compared to standard step and shot IMRT 
plans. 
Materials and Methods: The 2D-bMLC consists of individually 
controlled absorbers arranged side by side forming a 2d aperture. The 
design, which leads to radiation fields fragmented into stripes (fig a), 
aims at aperture changes below 100 ms. Within the TPS a treatment 
machine with a FFF 7MV linac source, a 2D-bMLC, a max dose rate of 
2000 MU/min and a SAD of 800 mm was modeled. The total fraction 
dose is delivered in one gantry rotation with constant speed. 
Treatment plans are generated for a predefined delivery time TF (fig 
b). The TPS uses a PB dose algorithm and the 48 arc segments are 
approx. by fixed beam directions. For a prostate patient (patient I) 
median doses of 76 Gy and 70 Gy in 35 fraction were prescribed to the 
GTV and the PTV respectively. For the rectum a dose constraint of 
D50% < 40 Gy was used. For Patient II with a nasopharyngeal carcinoma 
54 Gy in 30 fractions were prescribed to the PTV and 66 Gy to the 
boost region. Constraints for the spinal cord were D1% < 40 Gy, for the 
parotids D50% < 30 Gy; Dmean < 26 Gy. For both patients, plans with TF of 
20s (plan P20), 30s (P30) and 60s (P60) were generated and compared 
to clinically accepted 9-field IMRT plans. D99%, D50%, D1%, Dmean, 95% 
coverage and inhomogeneity (TDI) for the targets as well as the mean 
dose to the normal tissue, excluding the PTV, were calculated.  An 
additional tool was developed to compute the 2D-bMLC plans with a 
MC (Geant4.9.5) method, including a realistic model of the collimator 
absorber and gantry dynamic. 
 
  
Results: All 2D-bMLC plans calculated with the TPS fulfill the clinical 
goals. In the table (fig c), dose parameters are shown for patient I. 
Concerning the coverage and the TDI, the plans are in good agreement 
with the IMRT plan. Relative differences are below 1% while D50% to 
the rectum was decreased with P60 and P30. For patient II, coverage 
of the boost region is reduced by ~1% while PTV coverage is improved 
from 91.0% (IMRT) to 97.2% (P60), 96.7% (P30), 94.7% (P20). TDI for 
the boost region is similar for all plans. D1% to the spinal cord and D50% 
and Dmean to the parotids are slightly decreased (diff. < 3 Gy). Dmean to 
the normal tissue is decreased by > 10%. Compared to the TPS 
calculations the MC computed plans show increased values of D50% and 
D1% for the targets as well as increased TDI. P30 and P20 might need 
rescaling to assure adequate target coverage. Also Dmean to the normal 
tissue is increased in the MC plans. 
Conclusions: The 2D-bMLC plans fulfill the clinical goals and the 
relevant dosimetric parameters are comparable to the IMRT plans; 
Sparing of OARs is slightly improved. The 4D-MC tool allows to 
recompute the plans including the full dynamic of the delivery 
machine. 
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Purpose/Objective: The Papillon P50 (Ariane Medical Systems, Derby, 
UK) is a relatively new radiotherapy treatment machine delivering low 
energy x-rays (50 kV generating potential) for contact radiotherapy 
and IORT (Intra-Operative Radiotherapy). In contact radiotherapy the 
end of the treatment machine is brought into contact with the 
tumour. The size of the field is small (<= 3 cm dia.) and the distance 
from the source to the tumour is very short (≈3-4 cm). In this study a 
Monte Carlo simulation of the Papillon P50 is created to verify that 
the parameters in the UK Dosimetry Code of Practice (Klevenhagen et 
al. 1996, Phys. Med. Biol. 41, 2605) are applicable to this new regime: 
specifically backscatter factor, chamber factor and mass energy-
absorption coefficient ratio. These values are currently extrapolated 
due to the short SSD and small field size.  
Materials and Methods: Geant 4 was used to construct a virtual 
representation of the Papillon P50 geometry. The beam spectrum of 
the Papillon P50 was simulated by creating a 50 keV electron beam 
 
